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Lung cancer is one of the most common and lethal neoplasms for which very few
efficacious treatments are currently available. M1-like polarised tumour-associated
macrophages (TAMs) are key mediators to modulate the tumour microenvironment,
which play a key role in inhibiting cancer cell growth. Sophoridine, a naturally occurring
alkaloid, exerts multiple pharmacological activities including anti-tumour and anti-
inflammatory activities, but it has not been characterised as a regulator of tumour
microenvironment towards NSCLC. Herein, the regulatory effects of sophoridine on the
polarisation of THP-1 cells into TAMs and the anti-tumour effects of sophoridine-
stimulated M1 polarised macrophages towards lung cancer cells were carefully
investigated both in vitro and in vivo. The results showed that sophoridine could
significantly promote M1 polarisation of RAW264.7 and THP-1-derived macrophages,
leading to increased expression of pro-inflammatory cytokines and the M1 surface
markers CD86 via activating MAPKs signaling pathway. Further investigations showed
that sophoridine-stimulated RAW264.7 and THP-1-derived M1 macrophages effectively
induced cell apoptosis as well as inhibited the cell colony formation and cell proliferation in
both H460 and Lewis lung cancer cells. In Lewis-bearing mice model, sophoridine (15 or
25 mg/kg) significantly inhibited the tumour growth and up-regulated the expression of
CD86/F4/80 in tumour tissues. Collectively, the findings clearly demonstrate that
sophoridine promoted M1-like polarisation in vitro and in vivo, suggesting that
sophoridine held a great therapeutic potential for treating lung cancer.
Keywords: macrophage differentiation, mitogen-activated protein kinase (MPKs) pathway, sophoridine, RAW264.7,
THP-1 cellsFebruary 2021 | Volume 11 | Article 6348511
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Lung cancer is one of the leading causes of cancer-related
mortality over the world, and its 5-year survival rate is less
than 18% (1). Approximately 1.8 million lung cancer patients are
diagnosed annually, 80% of which present with an advanced
stage disease (2). 80% of lung cancer cases are non-small cell lung
cancer (NSCLC). The prognosis of NSCLC patients remains
poor in spite of several advances in early detection and
systematic therapies. The high mortality rate of NSCLC is
mainly responsible for the difficulty of early detection for
prognosis, high risk of metastasis, and inadequate reactions to
chemical therapy and radiotherapy (3). Since no curative therapy
has been developed to date for the developed lung cancer, clinical
care is mostly palliative (4). It is therefore necessary to gain deep
insight into the fundamental biological and molecular
mechanisms of the progression of NSCLC.
Intercommunication between the tumour and its
microenvironment contributes to several steps of cancer
development (5). Tumour-associated macrophages (TAMs) are
the macrophages that migrate to the stroma of tumour (6). Both
tissue-resident macrophages and monocyte-derived
macrophages are employed during the inflammation (7).
Classically activated macrophages (M1s) and the alternatively
active macrophages (M2s) are two major macrophage
polarisation states and also represent the Th1/Th2
differentiation paradigm (8). Th1-related cytokines, including
LPS, polarise macrophages to the M1 phenotype, producing a
high level of pro-inflammatory cytokines, such as IL-6, IL-1b,
TNF-a, reactive oxygen, and nitrogen species (9, 10). In
comparison, IL-4 activates macrophages to differentiate into
M2 phenotype, exerting anti-inflammatory and pro-
tumourigenic properties (11, 12). MAPKs signalling pathway is
involved in the inflammatory activation of macrophages and
reprogramming TAMs towards the M1 phenotype (13, 14).
Depletion of TAMs or inducing macrophage M1 polarisation
status via MAPKs signalling pathway is taken to be a promising
therapeutic strategy for treating NSCLC.
The combination of traditional therapies with natural
compounds has shown an additive effect due to the alternative
activation of the signalling pathway, which can lead to cell death
or improve the efficiency of the chemotherapeutic agents (15).
The participation in cancer immunobiology of these natural
compounds (either alone or in combination therapy) may offer
potential therapeutic possibilities (16). Herbal medicines contain
numerous of biologically active natural compounds, which have
been reported to have remarkable therapeutic efficacy with
minimal adverse effects and also as a major source for
discovery of drug lead compounds (17). Sophoridine
(C15H24N2O, Figure 1A) is a bioactive quinolizidine alkaloid
isolated from the leaves of Sophora alopecuroides. L (18). Studies
have revealed that sophoridine exhibited impressive viral
pharmacological effects, including anti-inflammatory, anti-
virus, and anti-cancer effects (19). The anti-tumour effects of
sophoridine are involved in several underlying mechanisms,
including arresting the cell cycle of pancreatic cancer cells in
the S or G0/G1 phase through activation of the phosphorylationFrontiers in Oncology | www.frontiersin.org 2of MAPK signalling pathways (20), inhibiting the tumour
progression and invasion in human colorectal cancer cells (21),
and inhibiting ubiquitin-proteasome signalling pathway in
human glioma cells (22). Sophoridine has been reported (23)
to have the ability of forming the gastric cancer immune
microenvironment by transferring TAM polarisation to M1
and suppressing M2-TAM polarisation. However, only one
study (24) reported that sophoridine exerted anti-tumour
effects via activation of p53 and Hippo signalling pathways
towards lung cancer cells. It has not been reported whether
sophoridine could inhibit the growth of lung cancer cells via
promoting TAM polarisation to pro-inflammatory M1 status or
regulating the tumour microenvironment.
Herein, the regulatory effects of sophoridine on the
differentiation of THP-1 cells into macrophages and the anti-
tumour effects of sophoridine-stimulated M1 polarised
macrophages towards lung cancer cells were investigated both in
vitro and in vivo. Surface markers and cytokine production were
employed to confirm the TAM polarisation to pro-inflammatory
M1 status. The findings in this study clearly demonstrated that
sophoridine was capable of promoting the polarisation of
RAW264.7 and THP-1 cells into M1-like macrophages.
The anti-tumour effects of sophoridine-stimulated M1 polarised
macrophages were evaluated via co-culturing with lung cell lines
(H460 and Lewis lung cancer cells). In addition, the in vivo
anticancer effects of sophoridine were investigated in a
subcutaneous xenograft tumour mice model (Figure 2).MATERIALS AND METHODS
Reagents and Antibodies
Sophoridine powder was purchased from MCE (purity > 98%).
Anti-human/mouse CD86 PE, anti-human/mouse CD11b FITC,
anti-mouse F4/80 FITC were purchased from BioLegend (CA,
USA). Antibodies against total and phosphorylated MAPK, Ki67,
F4/80 and CD86, and GAPDH were purchased from Cell
Signaling Technology (MA, USA). SP600125 were purchased
from MCE (NJ, USA). LPS and Phorbol 12-myristate 13-acetate
(PMA) was obtained from Sigma-Aldrich (MO, USA).Cell lines and Cell Culture
The human and mouse lung cancer cell lines, H460 and Lewis,
the human monocyte cell line, THP-1, and the mouse
macrophages, RAW264.7, were kindly provided by the Chinese
Academy of Sciences, China (Shanghai, China). Lewis and
RAW264.7 cells were cultured in DMEM medium (Gibco, NY,
USA), while H460 and THP-1 cells were cultured in RPMI-1640
medium (Gibco). All cultures were supplemented with 10% fetal
bovine serum (Gibco) and 100 U/ml penicillin–streptomycin
(Sigma-Aldrich). The cultures were kept under 5% CO2 at 37°C.
THP-1 was differentiated into macrophages-like phenotype by
stimulating with 150 nM PMA. The macrophages were polarised
into M1 by 1 mg/ml LPS for 24 h. M0 macrophages were
stimulated with 20 or 40 mg/ml sophoridine for 24 h.February 2021 | Volume 11 | Article 634851







FIGURE 1 | Sophoridine promoted macrophages shifting to M1 phenotype. (A) Chemical structure of sophoridine (downloaded from PubChem). (B, C) The cell
viability of sophoridine-stimulated RAW264.7 and THP-1-derived macrophages was detected by CCK-8 assay. (D, E) The percentage of CD86 of RAW264.7 and
THP-1-derived macrophages. (F, G) The relative expression of IFN-g, TNF-a, IL-6, iNOS, and IL-1b mRNA in RAW264.7 and THP-1-derived macrophages
determined by RT-PCR. (H, I) The NO production of RAW264.7 and THP-1-derived macrophages assessed by Griess. (J, K) The protein expression (% of GAPDH)
of TNF-a and IL-1b in RAW264.7 and THP-1-derived macrophages determine by Western blotting (n = 3), p < 0.05 (*).Frontiers in Oncology | www.frontiersin.org February 2021 | Volume 11 | Article 6348513
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co-cultured with Lewis and H460, respectively.
Conditioned Medium Preparation
Cell supernatants of macrophages were harvested after an
additional 24 h of culture. The supernatants were centrifugated
at 2,000 rpm for 10 min, and filtrated through a 0.22 µm cell
strainer. Supernatants were collected as conditioned medium
and stored at −80°C.
CCK-8 Assays
After stimulating with different concentrations of sophoridine, the
cell viability was detected using CCK-8 assay (Dojindo,
Kumamato, Japan). The cells were seeded in 96-well flat plates at
a density of 5 × 103 cell/ml. After the indicated incubation time, 10
ml of CCK-8 reagent was added into each well. Cells were cultured
for 1.5 h. The OD value of each well was detected at 450 nm. Cell
viability rate (%) = OD450(test)/OD450 (control) × 100%.
Flow Cytometry
After 24 h incubation, cells were washed with staining buffer
(BioLegend. CA, USA), then incubated with anti-human/mouse
PE-CD86 or human/mouse FITC-CD11b at room temperature
for 20 min. Afterwards, the cells were collected, washed, and
resuspended in cell staining buffer. Spleens were filtered through
40 mm nylon mesh strainer, and then were lysed for 5 min by
using 1× Red Blood Cell Lysis Buffer. Cells were double stained
with mouse FITC-CD11b and PE-CD86 fluorescently tagged
antibodies. All data were detected by a CytExpert flow cytometer
system and analysed by FlowJo software.
RT-PCR analysis
Total RNA was isolated with Trizol (Sigma-Aldrich) method.
cDNA was synthesised using the PrimeScript II 1st Strand cDNA
Synthesis Kit (Takara, Tokyo, Japan). The mRNA expression was
prepared by RT-PCR with SYBR Green PC Master Mix (Applied
Biosystems, USA). The primer sets used were as follows: Mouse:
IL-6: forward: ATAGGTGGACTGGACTCCCGA, reverse: TTT
GGTGCTTCACAATTCAG; TNF-a: forward: GCGACGTGGA
ACTGGCAGAAG, reverse: GCCACAAGCAGGAATGAGA
AGAGG; IL-1b : forward: ATGGCAATGTTCCTGAAC
TCAACT, reverse: CAGGACAGGTATAGATTCTTTCCTTT;
iNOS: forward: GGACCCAGTGCCCTGCTTT, reverse: CACC
AAGCTCATGCGGCCT; b-actin: forward: TGGAATCCTGT
GGCATCCATGAAAC, reverse: TAAAACGCAGCTCAGTAA
CAGTCCG; Human: IL-1b: forward: TGCTCAAGTGTCTGA
AGCAG, reverse: TGGTGGTCGGAGATTCGTAG; TNF-a:
forward: CCCAGGGACCTCTCTCTAATC, reverse: ATGGGC
TACAGGCTTGTCACT; IL-6: forward: ACCCTGACCAT
CCAAGTCAAA, reverse: TTGGCCTCGCATCTTAGAAAG;
iNOS: forward: TGGAGCCAGTTGTGGATTGTC, reverse:
GGTCGTAATGTCCAGGAAGTAG; GAPDH: forward: CACC
AACTGCTTAGCACCCC, reverse: TGGTCATGAGTCCT
TCCACG. Thermocycler conditions: initial holding at 50°C for
2 min; 95°C for 5 min and 15 s; 60°C for 15 s; 72°C for 30 s for 40
cycle sandals; holding at 72°C for 5 s. Reactions were conductedFrontiers in Oncology | www.frontiersin.org 4using an ABI PRISM® 7,300 Sequence Detection System
(Applied Biosystems, Canada). The results were expressed as
RQ = 2− DDCt.
Griess Test
20 and 40 mg/ml sophoridine or 1 mg/ml LPS was added for 24 h.
After the incubation, cell supernatants were collected for the
measurement of Nitric Oxide (NO) by using NO assay kit
(Sigma-Aldrich), and incubated for 10 min. A microplate
reader was used to detect the OD value at 540 nm.
Western Blot Analysis
Proteins (10 mg/lane) was dissolved in sodium dodecyl sulfate
(SDS)-polyacrylamide gels and transferred onto a polyvinyl
difluoride (PVDF) membrane (Millipore), then incubated
overnight with primary antibody at 4°C. The blots were
incubated with secondary antibodies for 2 h. The results were
analysed using ImageJ software (National Institutes of Health,
Maryland, USA).
Cell apoptosis Assay
Cells were collected after 24 h incubation. The cell apoptosis was
analysed using an Annexin V-FITC/PI Apoptosis Detection Kit
(V13241) (Thermo, MA, USA). All samples were detected using
a CytExpert flow cytometer (Beckman Coulter, USA).
Colony Formation, Cell Cycle, and Cell
Proliferation Analysis
Cells were seeded in 12-well flat plates at a density of 900 cells/
well and incubated for 10 d. Cells were fixed with 4%
paraformaldehyde (Beyotime, Shanghai, China) for 15 min and
stained with crystal violet (Beyotime) for 15 min. Glacial acetic
acid was added after taking pictures; the OD value of each well
was detected at 590 nm. For cell cycle assay, the cells were
stimulated with sophoridine (20 and 40 mg/ml) for 24 h. Cells
were fixed with 70% ethanol at −20°C overnight. DNA content
was detected by PI staining. Cell proliferation was measured
using the 5-ethynyl-2′-deoxyuridine (EdU) staining. Cells (1 ×
105/ml) were incubated with 1 µM EdU solution (Thermo Fisher
Scientific, Inc.) for 2 h, and then stained with 1× Hoechst 33342
solution (Beyotime) for 10 min at 25°C. The morphologic
changes were observed using a fluorescence microscope
(magnification, ×100).
Measuring of Intracellular Reactive
Oxygen Species
To measure the intracellular ROS level, the diluted DCFH-DA
was added to the incubated cells for 30 min at 25°C in the dark.
The intensity of fluorescence was detected using a CytExpert
flow cytometer.
Lewis Lung Cancer Tumour Xenograft
Mice Experiment
Female C57BL/6J mice (6-week-old) were conducted in
compliance with the relevant laws and institutional guidelines.February 2021 | Volume 11 | Article 634851
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Committee of Shanghai Institute of Food and Drug Control (the
approval No. SIFDC18096). LLC cells (8 × 105 cells) in 0.2 ml of
PBS were injected subcutaneously into the right back side of the
mouse. After 1 d, mice were intragastric (i.g.) administrated with
0.2 ml of sophoridine (15 mg/kg) and 0.2 ml of sophoridine (25
mg/kg) for 25 d.
Haematoxylin–Eosin
and Immunohistochemistry Staining
Tissue (heart, liver, kidney, and spleen) slides were stained with
H&E. Slides were observed using a microscope (×100
magnification) for six fields. The expression of Ki67 was
quantitatively evaluated using a fluorescence microscope
(×100 magnification).
Immunofluorescent Staining
To analyse the expression of M1-like macrophages in tumour
tissues, tumour tissues were fixed by 4% paraformaldehyde for
10 min. Then, all tissues made into paraffin were cut at a
thickness of 4 mm. For immunofluorescence, the primary
antibodies were employed: F4/80 (1:500) and CD86 (1:500).
For morphometric evaluation, five optical fields/tumour section
were randomly chosen and imaged by a fluorescence microscope.
Statistical Analysis
Values are expressed in Mean ± Standard Deviation of three
independent experiments. GraphPad Prism 8.0 software (San
Diego, CA, USA) was employed to analyse data. The difference
between groups was measured using Unpaired Student’s t-test
(two-tailed) and one-way ANOVA test. Values with p <0.05 (*)
mean statistically different.RESULTS
Sophoridine Promoted Macrophages
Switching to M1 Phenotype
The effects of sophoridine on cell viability of RAW 264.7 and
THP-1-derived macrophages were measured by CCK-8 assay. As
shown in Figures 1B, C, 10, 20, and 40 mg/ml sophoridine
displayed negligible effects on cell viability compared to the
untreated control groups (p > 0.05). Herein, 20 and 40 mg/ml
sophoridine were used for subsequent experiments.
To determine whether sophoridine induced M1 macrophages
polarisation, CD86, a co-stimulatory molecule, which is a
differentiated marker of macrophages, was detected by flow
cytometry analysis. As shown in Figures 1D, E, stimulated with
LPS alone induced macrophages polarising to M1 phenotype, and
the expressions of CD86 of RAW 264.7 and THP-1 macrophages
were more than 80%. When treated with 20 or 40 mg/ml
sophoridine, the expressions of CD86 marker of macrophages
increased significantly compared to the control cells (p < 0.05).
Moreover, THP-1 cells stimulated by sophoridine showed an
approximately two to three-fold increase in the expression of
CD86 surfacemarker relative to PMA-differentiatedmacrophages.Frontiers in Oncology | www.frontiersin.org 5To further evaluate the effects of sophoridine on the release of
the classic cytokines of M1-like macrophage, RT-PCR was
carried out to detect the expression of IFN-g, IL-1b, TNF-a,
IL-6, and iNOS of RAW264.7 and THP-1-derived macrophages.
As shown in Figure 1F, upon exposure to LPS or sophoridine,
RAW264.7 produced noticeably greater amounts of iNOS
compared to the untreated cells, followed by IFN-g and TNF-
a. Figure 1G presents that LPS- or sophoridine-stimulated THP-
1-derived macrophages produced higher levels of pro-
inflammatory cytokines of M1-like macrophage compared to
the control cells (p < 0.05). Sophoridine induced the cytokine
production of M1 macrophages in a.
In order to further determine whether sophoridine could up-
regulate pro-inflammatory cytokines of M1 macrophages, the
protein expressions of TNF-a and IL-1b were also detected by
Western blotting. As shown in Figures 1J, K, LPS and
sophoridine up-regulated the expression of TNF-a and IL-1b
in both RAW264.7 and THP-1-derived macrophages. The results
were highly consistent with the mRNA expression of TNF-a and
IL-1b.
The results of mRNA expression of iNOS in macrophages
(Figures 1F, G) showed that sophoridine increased the mRNA
expression of iNOS in RAW264.7 and THP-1-derivedmacrophages
compared to the control cells. NO production was further
quantified by Griess in this study, and the effects of sophoridine
on the release of NO in RAW264.7 and THP-1-derived
macrophages were depicted in Figures 1H, I. LPS-stimulated
RAW264.7 produced 22.5 mmoL/L NO, while 20 and 40 mg/ml
sophoridine-stimulated RAW264.7 released 16 and 18 mmoL/L NO,
respectively, which were up to 16- to 18-fold higher than the control
level (p < 0.05). The level of NO production was also consistent with
the mRNA expression of iNOS.
To determine whether sophoridine inhibits IL-4 and IL-13-
induced RAW264.7 macrophage M2 polarisation, we detected
the expression of the surface markers CD206 by flow cytometry
in M2 macrophages after treatment with sophoridine. As shown
in Supplementary Figure 1, significant up-regulation of CD206
was observed when RAW24.7 monocytes were treated with IL-4
and IL-13 for 24 h, and this was greatly reduced by sophoridine.
MAPK Signalling Pathway Regulated
the Sophoridine-Induced Differentiation
and the Production of Pro-Inflammatory
Cytokines
As macrophage polarisation needs the activation of unique
transcription factors; the potential signalling pathways involved
in sophoridine-stimulated M1 macrophage polarisation need to
be further elucidated. The MAPK signalling pathway, which has
been proved to play an essential role in mediating inflammatory
response (25), was carried out. Prior to the sophoridine
stimulation, a JNK inhibitor, SP600125, was employed to
evaluate its effect on MAPK signalling pathway. SP600125
down-regulated the expression of p-JNK of RAW246.7 and
THP-1-derived macrophages compared to untreated cells
(Supplementary Figure 1). Hence, SP600125 blocked the
MAPK signalling pathway via inactivation of p-JNK. Afterwards,February 2021 | Volume 11 | Article 634851
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sophoridine to determine whether sophoridine can induce theM1
macrophages polarisation. According to the Figures 3A, B, LPS
and sophoridine (20 and 40 mg/ml) triggered the phosphorylation
of JNK, ERK, and p38 MAPK in RAW264.7 and THP-1-derived
macrophages. RAW264.7 and THP-1 cells were pre-treated with
SP600125, and then stimulated with or without sophoridine (20
and 40 mg/ml). The expression of surface markers, CD86 and
CD11b (Figures 3C, D) as well as pro-inflammatory cytokines,
including IL-1b, IFN-g, TNF-a, iNOS, and IL-6 (Figures 3E, F) in
macrophages were detected by flow cytometry and RT-PCR
analysis, respectively. The expression of CD86 and the pro-
inflammatory cytokines in RAW264.7 and THP-1-derived
macrophages was partly prevented by SP600125. Although
RAW264.7 and THP-1-derived macrophages were co-stimulated
with 20/40 mg/ml sophoridine, the mRNA expressions of IFN-g,
TNF-a, IL-6, iNOS, and IL-1b were significantly lower than that
of stimulated with sophoridine alone (p < 0.05). In addition, pre-
treatment with SP600125 down-regulated the expression of CD86
in sophoridine-stimulated macrophages when compared with the
macrophages without pre-treatment with SP600125. Besides,
the expression of NO in RAW264.7 and THP-1-derived
macrophages was measured. After pre-treating with SP600125
on sophoridine-stimulated RAW264.7 and THP-1-derived
macrophages, the NO production was considerably lower than
the macrophages without treatment with SP600125 (Figures 3G,
H, p < 0.05). This result was consistent with the down-regulated
mRNA expression of iNOS.
Sophoridine-Stimulated Macrophage-Lung
Cancer Cell Crosstalk Induced Cell
Apoptosis
The supernatants of sophoridine-treated RAW264.7 and THP-1-
derivedmacrophages were collected and co-cultured with H460 and
Lewis lung cancer cells, respectively. Cell colony formation, cell
apoptosis, and distribution of the cell cycle were conducted onH460
and Lewis cells. Prior to these analyses, H460 and Lewis cells were
stimulated with various concentrations of sophoridine alone for
48 h. The results show that the IC50 for H460 and Lewis was 73.49
and 64.95 mg/ml at 24 h and 53.52 and 40.10 mg/ml at 48 h,
respectively (Supplementary Figure 2), demonstrating that
sophoridine inhibited the growth of H460 and Lewis cells.
The apoptotic rate of H460 and Lewis cells was measured.
Infiltration of H460 and Lewis lung cancer cells with sophoridine-
induced RAW264.7 and THP-1-derived macrophages,
respectively, significantly increased the percentages of the later
and early apoptotic rate of lung cancer cells compared to the
untreated and sophoridine-treated alone H460 and Lewis cells (p
< 0.05) (Figure 4A). These results suggested that 20 and 40 mg/ml
sophoridine-stimulated macrophages effectively induced the cell
apoptosis of H460 and Lewis cells. Quantitative analysis of
colony formation in Figure 4B demonstrates that the colony
formations of macrophages infiltrated H460 and Lewis cancer
cells were significantly lower than control and sophoridine-
treated alone lung cancer cells (p < 0.05). This trend was in
agreement with the results of cell apoptosis of H460 and LewisFrontiers in Oncology | www.frontiersin.org 6cells, suggesting that sophoridine-stimulated macrophages
significantly effectively inhibited cell colony forming activities
of H460 and Lewis lung cancer cells at the doses of 20 and
40 mg/ml.
Morphologic changes and cell proliferation of lung cancer
cells were detected after the Hoechst and EdU staining. The
obvious apoptotic features, such as nuclear shrinkage, irregular
condensation of chromatin, and apoptotic bodies, were detected
in sophoridine stimulated-H460 and Lewis cells (Figure 4C, blue
staining). In addition, the area of the red staining, representing
the cell proliferation, decreased dramatically in macrophages
infiltrated H460 and Lewis cells compared to untreated cells.
Moreover, this phenomenon seemed to be more obvious
compared to those in Lewis lung cancer cells. These results
revealed that sophoridine-stimulated macrophages at the doses
of 20 and 40 mg/ml induced the cell apoptosis and suppressed the
cell proliferation of lung cancer cells.
Figure 4D shows the percentage of cell number in each
phase of cell cycle of H460 and Lewis cells. The percentage of
THP-1-infiltrated H460 cells in the G2/M phase significantly
increased, whilst the percentage of RAW264.7-infiltrated
Lewis cells in the S and G2/M phases increased when
compared with the untreated cells (p < 0.05). The arrest effect
in macrophage-infiltrated cells was more significant than in lung
cancer cells stimulated with sophoridine alone (p < 0.05). These
results suggested that sophoridine-stimulated THP-1-derived
arrested the cell cycle of H460 in the G2/M phase, while
sophoridine-stimulated RAW264.7 macrophages arrested the
cell cycle of Lewis cells in the S phase partially and the G2/
M phase.
The ROS generation in two lung cancer cells was detected by
flow cytometry analysis, and the results are shown in Figure 4E.
The ROS generation increased considerably in sophoridine-
stimulated macrophages infiltrated compared to untreated cells
(p < 0.05). M1 polarised macrophages infiltrated lung cancer cells
generated greater ROS than sophoridine-administrated.Sophoridine Inhibited Tumour Growth
In Vivo
Figures 5A, B present that oral administration of sophoridine at
doses of 15 and 25 mg/kg significantly suppressed tumour
growth markedly, which was reflected by the decrease of the
volume and the weight of tumour, and the final volume and the
weight of tumour from mice administrated with sophoridine
were significantly lower than those from control mice (p < 0.05).
Consistent with the results in Figure 5C, 15 and 25 mg/kg
sophoridine induced the destruction of architectures of tumour
tissues, and the infiltration of large number of inflammatory cells
into tumour tissues reflected by H&E staining.
The IHC staining of Ki67 (Figure 5C) presents that the
tumour tissues from mice administrated with sophoridine had
less positive staining compared to the untreated mice (p < 0.05),
indicating that administration of sophoridine at the doses of 15
and 25 mg/kg significantly inhibited the expression of Ki67 in
tumour tissues. These pathological analyses indicated that theFebruary 2021 | Volume 11 | Article 634851
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tumour growth.
Sophoridine Promoted M1 Polarisation
of Macrophages In Vivo
The lung sections from different groups were double stained
with the M1-marker CD86 and the macrophage marker F4/80.
The results are shown in Figure 6A; sophoridine increased the
percentage of CD86 significantly. Flow cytometry analysis was
also employed to measure the ratio of CD86 to F4/80. The
result of spleen in Figure 6B was consistent with the staining
results, presenting that sophoridine increased the ratio of
CD86/F4/80.
Sophoridine Had No Toxicity Toward
Heart/Kidney/Spleen/Liver
The in vivo toxicity of sophoridine was evaluated in mice.
Following oral administration of sophoridine at the doses of 15
and 25 mg/kg for 25 days, the systemic toxicity was evaluated by
H&E staining. As shown in Figure 7, there was no obvious
difference between control groups and sophoridine-
administration groups. The tissues collected from mice were
stained with H&E to further monitor the cardiac, liver, spleen,
and kidney toxicity after the oral administration. The histological
structure of the heart, kidney, liver, and spleen was observed andFrontiers in Oncology | www.frontiersin.org 7compared microscopically. There was no obvious histological
change after oral administration of sophoridine. These findings
revealed that sophoridine was an effective agent, which
suppressed the xenograft lung tumour growth in vivo, with
well-tolerated toxicity.DISCUSSION
Monocyte-to-macrophage differentiation is a vital stage during
the onset of immune responses. THP-1 cell has been widely
employed to investigate the function activity and the
differentiation of monocyte and macrophage in vitro (26).
PMA is considered as the most effective stimulating agent to
induce the differentiation of THP-1 cells, which can represent a
simplified macrophage model (27). In this study, PMA was
employed to induce the differentiation of THP-1 cells to
macrophages, and PMA-stimulated THP-1-derived macrophages
were used for subsequent experiments.
CD86, a co-stimulatory molecule, which is the differentiated
marker of macrophages, was detected in this study. The up-
regulated expression of CD86 surface marker revealed that
sophoridine stimulated RAW264.7 and THP-1 cells to
differentiate into macrophage-like cells and might induce
macrophages polarising to M1 phenotype. M1 phenotypeFIGURE 2 | Sophoridine induced macrophages M1 polarisation via MAPKs pathway.February 2021 | Volume 11 | Article 634851






FIGURE 3 | The sophoridine induced macrophages differentiation and produced pro-inflammatory cytokines via the MAPKs signaling pathway (A, B) The relative
protein expression of p-JNK, p-ERK, and p-P38 (relative to JNK, ERK, and P38, respectively) in RAW264.7 and THP-1-derived macrophages determine by Western
Blotting. (C, D) The percentage of CD86 of sophoridine-stimulated RAW264.7 and THP-1-derived macrophages with or without SP600125 treatment. (E, F) The
relative expression of IFN-g, TNF-a, IL-6, iNOS, and IL-1b mRNA in sophoridine-stimulated RAW264.7 and THP-1-derived macrophages with or without SP600125
treatment determine by RT-PCR. (G, H) The NO production of sophoridine-stimulated RAW264.7 and THP-1-derived macrophages with or without SP600125
treatment (n = 3), p < 0.05 (*).Frontiers in Oncology | www.frontiersin.org February 2021 | Volume 11 | Article 6348518





FIGURE 4 | Sophoridine-stimulated macrophage-lung cancer cell crosstalk induced cell apoptosis, cell colony formation, and suppressed cell proliferation. (A) The
cell apoptosis of H460 with or without infiltration of sophoridine-stimulated THP-1-derived macrophages, and Lewis lung cancer cells with or without sophoridine-
stimulated RAW264.7 macrophages determine by flow cytometry analysis. (B) The cell colony formation of H460 with or without infiltration of sophoridine-stimulated
THP-1-derived macrophages, and Lewis lung cancer cells with or without sophoridine-stimulated RAW264.7 macrophages. (C) The cell proliferation and apoptosis
of H460 with or without infiltration of sophoridine-stimulated THP-1-derived macrophages, and Lewis lung cancer cells with or without sophoridine-stimulated
RAW264.7 macrophages determine by EdU and Hoechst staining. (D) The percentage of cell number in the G1, S, and G2/M phase during the cell cycle of H460
with or without infiltration of sophoridine-stimulated THP-1-derived macrophages, and Lewis lung cancer cells with or without sophoridine-stimulated RAW264.7
macrophages detect by flow cytometry using PI staining. (E) ROS intensity with or without infiltration of sophoridine-stimulated macrophages (n = 3), p < 0.05 (*).Frontiers in Oncology | www.frontiersin.org February 2021 | Volume 11 | Article 6348519
Zhao et al. Sophoridine Inhibited NSLC Tumour Growthproduces pro-inflammatory cytokines and plays a critical role in
microbial and tumour regression, while M2 expresses anti-
inflammatory factors and participants in the immune regulation
and tumour progression. In the tumour microenvironment, the
TAMs adopt an immunosuppressive M2-like phenotype
important to promote cancer growth. To further evaluate the
influences of sophoridine on the production of the typical
cytokines of M1 macrophage, the expression of IFN-g, TNF-a,
IL-6, IL-1b, and iNOS was measured. The results indicated that
sophoridine induced the cytokines production of M1
macrophages. Pathogens, in particular of those containing LPS,
induce chronic inflammation (28), which is related to the increase
in NO production. Macrophages appear to be the major cellular
source of NO (29). Previous studies have demonstrated LPS-
stimulated macrophages produced high level of NO, thus
leading to the macrophage’s differentiation. iNOS is the primary
enzyme and makes the great contributions to the NO production
in inflammatory processes (30). A change in iNOS activity directly
affects the production of NO (31). This study demonstrated that
sophoridine induced the activation of iNOS activity of
macrophages to produce NO, thus leading to the M1-
macrophages polarisation. Macrophage activation state is vital to
regulate between inflammation and resolution or tissue
homeostasis and disease pathogenesis. Moreover, it wasFrontiers in Oncology | www.frontiersin.org 10demonstrated that sophoridine inhibit skewing of M2-like
macrophages (Supplementary Figure 3). However, we need
more experiments to verify that sophoridine inhibits M2-
like macrophages.
MAPK signalling pathway has been reported to be
associated with macrophage activation and reprogramme
TAMs towards M1 macrophages polarisation (13, 14).
SP600125 was used to block the initiation of signal
transduction (32), and the results suggested that stimulation
of JNK inhibitor before polarising with LPS or sophoridine
blocked the induction of the M1 marker CD86 and decreased
the production of the M1 cytokines in sophoridine-stimulated
macrophages. In addition, iNOS activity and NO production
were drastically blocked by JNK inhibitor, which resulted in
the inhibition of iNOS activity, thus leading to the reduction
of NO production in sophoridine-stimulated RAW264.7 and
THP-1-derived macrophages. Taken together, these results
revealed that JNK acted as an initiator for activation of
MAPKs signalling pathway during the process of M1-like
macrophage polarisation. However, there are still some
limitations in this study. On the one hand, this study
focussed primarily on the MAPK signalling pathway, despite
any other potential mechanisms involved in the macrophage
polarisation. On the other hand, only CD86 was employed asA B
C
FIGURE 5 | Sophoridine inhibited tumour growth of Lewis-bearing mice and promoted M1 polarisation of macrophages in vivo. (A) Administration of 15 and 25 mg/
kg sophoridine decreased the tumour volume (mm3). (B) Administration of 15 and 25 mg/kg sophoridine decreased the tumour weigh. (C) Administration of 15 and
25 mg/kg sophoridine decreased the infiltration of inflammatory cells measured by H&E staining, and the expression of Ki67 measured by IHC staining, in tumour
tissues from Lewis-bearing mice p < 0.05 (*).February 2021 | Volume 11 | Article 634851
Zhao et al. Sophoridine Inhibited NSLC Tumour Growththe surface marker to discriminate macrophages. More
definitive biochemical markers to differentiate macrophage
populations are needed.
The interactions of lung cancer cells with the RAW264.7/THP-
1-derived macrophages are bidirectional. RAW264.7 and THP-1-
derivedmacrophages seem to be educated by the lung cancer cells to
lead to their activation under the co-culture conditions (33).
ROS generation plays a key role in several signalling
pathways. Elevated ROS in cancer cells promotes the cell
apoptosis in response to the cellular stress induced by
chemotherapy (34). Varieties of drugs have been reported to
exert their effects via the activation of induced the cell apoptosis
through ROS generation. ROS are the natural products of cellular
metabolism (35). Herein, infiltration with sophoridine-
stimulated macrophages induced the cell apoptosis and ROS
generation of lung cancer cells, indicating that ROS production
was an upstream regulator of sophoridine inducing lung cancer
cell apoptosis.
Sophoridine-stimulated macrophages arrested the cell cycle
of Lewis cells in the S phase partially as well as in the G2/M phase
which prevented DNA from replicating properly, and thus
inhibited the tumour growth. This result was agreement with a
previous study (21), reporting that sophoridine arrested the S
phase of pancreatic cancer cell cycle. The damage and error
induced by the cell cycle arrest, which occurs in the course of cell
division, are difficult to repair (36). Herein, sophoridine-
stimulated macrophages induced the DNA damage and cellFrontiers in Oncology | www.frontiersin.org 11cycle arrest, leading to the suppression of lung cancer cell
proliferation. Large numbers of macrophages infiltrated into
lung adenocarcinoma tissues were related to the poor patient
prognosis (37). The data obtained in this study revealed that the
RAW264.7 and THP-1-derived macrophages likely underwent
differentiation into M1-like macrophage, thus exerted biological
effects towards lung cancer cells. Therefore, RAW264.7 and
THP-1-derived macrophages and lung cancer cells altered the
behaviors mutually between each other. Furthermore, lung
cancer cells educated by macrophages acquired myeloid
features, including the properties of cell colony formation, cell
apoptosis, and cell proliferation.
High proliferation rate is a characteristic of cancer. Ki67 protein is
well characterised at the molecular level and is normally used as a
prognostic and predictive marker for the diagnosis and treatment of
cancers (38). Ki67 is rapidly degraded with a half-life of 1–1.5 h. This
makes the Ki-67 antigen an outstanding marker for the detection of
the cell proliferation in normal and tumour cell populations (39).
Therefore, it deserves further investigation and development, such as
testing in more sophisticated in vitro and appropriate in vivomodels.
Cellular proliferation can be identified by different methods, IHC
staining for the Ki-67 antigen has become widely used in
histopathology, especially as a proliferator in various tumour types.
High expression level of Ki-67 in the tumour tissue has been reported
to be associated with poor prognosis in NSCLC (38). However, a
study reported that Ki-67 level did not affect the survival rate of
cancer patients (40). In this study, after administration of sophoridine,A
B
FIGURE 6 | (A) The expression of CD86 and F4/80, determined by IHC. Scale bar: 50 mm (B) Administration of 15 and 25 mg/kg sophoridine increased the
expression of the ratio of CD86/F4/80 (n = 3), p < 0.05 (*).February 2021 | Volume 11 | Article 634851
Zhao et al. Sophoridine Inhibited NSLC Tumour Growththe expression of Ki67 in tumour tissues decreased considerably
compared to untreated mice. These results confirmed that
sophoridine inhibited the cell proliferation and demonstrated a
favorable anti-tumour effect in vivo.
Macrophages are the most prominent component of
leukocytes that infiltrate tumour-bearing mice and humans
with various types of cancers (41). Considering the influence
of sophoridine on tumour growth, the sophoridine-mediated
effects on altered TAM polarisation in tumour tissues in vivo
were investigated. These observations link TAMs highlighted
the anti-tumourigenic effect of sophoridine, specifically via
the MAPK signalling pathway, provided a promising
strategy to modulate the environment of lung cancer cells
and gave scientific support for the clinical application
of sophoridine.DATA AVAILABILITY STATEMENT
The original contributions presented in the study are included in
the article/Supplementary Material. Further inquiries can be
directed to the corresponding authors.Frontiers in Oncology | www.frontiersin.org 12ETHICS STATEMENT
The animal study was reviewed and approved by the Animal
Care and Use Committee of Shanghai Institute of Food and
Drug Control.AUTHOR CONTRIBUTIONS
GG, TL and BZ conceived and designed the study. BZ, XH, HZ,
YY, JH and QT performed the experiments. BZ and XH wrote
the paper. GG and TL reviewed and edited the manuscript. All
authors contributed to the article and approved the
submitted version.FUNDING
This work was financially supported by the grants of NSF of China
(81922070, 81973286, 81773687), the National Key Research and
Development Program of China (2020YFC0845400,FIGURE 7 | The toxicity of sophoridine on the heart, liver, kidney, and spleen tissues in vivo. The sections were stained with H&E staining. The pictures are
representative from control and 15 and 25 mg/kg sophoridine groups.February 2021 | Volume 11 | Article 634851
Zhao et al. Sophoridine Inhibited NSLC Tumour Growth2017YFC1700200, 2017YFC1702000), Program of Shanghai
Academic/Technology Research Leader (18XD1403600),
Shanghai Talent Development Fund (2019093), the Three-year
Action Plan of Shanghai TCM Development (ZY-(2018-2020)-
CCCX-5001), Natural Science Foundation of Shanghai
(No.19ZR1447800), Shuguang Program (18SG40) supported by
Shanghai Education Development Foundation and Shanghai
Municipal Education Commission, The Health System
Independent Innovation Science Foundation of Shanghai Putuo
District (ptkwws201802), and Shanghai Science and Technology
Commission Medical Guidance Project(19411972400).Frontiers in Oncology | www.frontiersin.org 13SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found online
at: https://www.frontiersin.org/articles/10.3389/fonc.2021.
634851/full#supplementary-material
Supplementary Figure 1 | SP600125 inhibited the expression of pJNK and JNK
in macrophages.
Supplementary Figure 2 | Sophoridine inhibited the growth of lung cancer cells
in dose-dependent manners.
Supplementary Figure 3 | Sophoridine suppressed M2 polarisation of
macrophages in vitro.REFERENCES
1. Barta JA, Powell C A, Wisnivesky JP. Global Epidemiology of Lung Cancer.
Ann Glob Health (2019) 85:8. doi: 10.5334/aogh.2419
2. Siegel RL, Miller K D, Jemal A. Cancer statistics, 2020. CA Cancer J Clin
(2020) 70:7–30. doi: 10.3322/caac.21590
3. Zappa C, Mousa SA. Non-small cell lung cancer: current treatment and future
advances. Transl Lung Cancer Res (2016) 5:288–300. doi: 10.21037/tlcr.2016.06.07
4. Lawrenson R, Lao C, Brown L, Moosa L, Chepulis L, Keenan R, et al.
Management of patients with early stage lung cancer – why do some
patients not receive treatment with curative intent? BMC Cancer (2020)
20:109. doi: 10.1186/s12885-020-6580-6
5. Baghban R, Roshangar L, Jahanban-Esfahlan R, Seidi K, Ebrahimi-KalanA, Jaymand
M, et al. Tumor microenvironment complexity and therapeutic implications at a
glance. Cell Commun Signaling (2020) 18:59. doi: 10.1186/s12964-020-0530-4
6. Hill BS, Sarnella A, D’Avino G, Zannetti A. Recruitment of stromal cells into
tumour microenvironment promote the metastatic spread of breast cancer.
Semin Cancer Biol (2020) 60:202–13. doi: 10.1016/j.semcancer.2019.07.028
7. Epelman S, Lavine K J, Randolph GJ. Origin and functions of tissue
macrophages. Immunity (2014) 41:21–35. doi: 10.1016/j.immuni.2014.06.013
8. Parisi L, Gini E, Baci D, Tremolati M, Fanuli M, Bassani B, et al. Macrophage
Polarization in Chronic Inflammatory Diseases: Killers or Builders?
J Immunol Res (2018) 2018:8917804–8917804. doi: 10.1155/2018/8917804
9. Atri C, Guerfali F Z, Laouini D. Role of Human Macrophage Polarization in
Inflammation during Infectious Diseases. Int J Mol Sci (2018) 19:1801. doi:
10.3390/ijms19061801
10. Arora S, Dev K, Agarwal B, Das P, Syed MA. Macrophages: Their role,
activation and polarization in pulmonary diseases. Immunobiology (2018)
223:383–96. doi: 10.1016/j.imbio.2017.11.001
11. Viola A, Munari F, Sánchez-Rodrıǵuez R, Scolaro T, Castegna A. The
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